1h Free Analyst Time
Increasing focus on customizing material properties to drive growth in the market. There is a growing focus on customizing the material properties of composite and bioabsorbable materials with fillers like bioactive ceramics for nonpermanent devices. PEEK biomaterials, which are variations of PAEK biomaterials, have been used in spinal implants, and as bearing materials for hip and knee replacement, and hip resurfacing. The analysts have predicted that the orthopedic biomaterials market will register a CAGR of close to 7% by 2022.
Speak directly to the analyst to clarify any post sales queries you may have.
Market Overview
Increasing prevalence of musculoskeletal diseases and disorders
The increasing burden of musculoskeletal disorders subsequently increases the demand for orthopedic biomaterials used to repair such conditions.
High cost of orthopedic bioimplants and surgeries
The high cost of orthopedic bioimplants and surgeries is restricting the widespread adoption of orthopedic biomaterials in several developed as well as developing countries.
For the detailed list of factors that will drive and challenge the growth of the orthopedic biomaterials market during the 2018-2022, view this report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Medtronic and Smith & Nephew, the competitive environment is quite intense. Factors such as the increasing prevalence of musculoskeletal diseases and disorders and the increasing focus on customizing material properties, will provide considerable growth opportunities to orthopedic biomaterials manufactures. B. Braun Melsungen, Johnson & Johnson, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet are some of the major companies covered in this report.
Table of Contents
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORTPART 03: RESEARCH METHODOLOGYPART 08: CUSTOMER LANDSCAPEPART 10: DECISION FRAMEWORK
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY APPLICATION
PART 09: REGIONAL LANDSCAPE
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
List of Exhibits
Executive Summary
Global Orthopedic Biomaterials Market 2018-2022The analyst recognizes the following companies as the key players in the global orthopedic biomaterials market: B. Braun Melsungen, Johnson & Johnson, Medtronic, Smith & Nephew, Stryker, and Zimmer Biomet.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing focus on customizing material properties.”
According to the report, one of the major drivers for this market is the increasing prevalence of musculoskeletal diseases and disorders.
Further, the report states that one of the major factors hindering the growth of this market is the high cost of orthopedic bioimplants and surgeries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- B. Braun Melsungen
- Johnson & Johnson
- Medtronic
- Smith & Nephew
- Stryker
- Zimmer Biomet
